Fewer than 10% of children or adolescents with peanut allergy passed a desnsitiaztion food challenge after receiving dupilumab for 24 weeks. Image: Adobe Stock “The impact of the findings for ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
No. 2 South Carolina women remain perfect in SEC by rolling past Georgia 74-42 for 17th straight win
ATHENS, Ga. (AP) — No. 2 South Carolina continued its domination of the Southeastern Conference, beating Georgia 74-42 on Thursday night for its 17th consecutive win while holding the Lady ...
As of Wednesday, the 2025 recruiting cycle is officially over. After a (9-3) regular season record, the South Carolina Gamecocks pushed hard to convert South Carolina coach Shane Beamer has made ...
A ranking of the top songs based on streaming and sales activity from within the country- as tracked by Luminate. The ranking is based on a weighted formula incorporating official-only streams ...
Sunday’s Super Bowl will have a definite Charlotte flavor with three former high school stars playing in the Big Game: Will Shipley, Jordan Davis (Eagles), DJ Humphries (Chiefs) Real-time ...
They collected skin tape strips (STS) from the lesional and non-lesional skin of 20 patients with AD and 20 healthy volunteers (HV) over 16 weeks of dupilumab treatment. STS extracts were analyzed ...
Walmart on Tuesday said it is eliminating some roles and closing its office in North Carolina, as part of its move to relocate employees to its main hubs in California and Arkansas, according to ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: asthma. This novel therapeutic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback